Finance

Beta
Lists
301258:SHE
Suzhou Fushilai Pharmaceutical Co Ltd
CN¥25.62
+0.95%
(+0.24) 1D
Jun 5, 3:04:28 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301258...
Open
CN¥25.60
High
CN¥25.95
Low
CN¥24.75
Mkt. cap
2.33B
Avg. vol.
1.14M
Volume
947.70K
Dividend
0.86%
Quarterly dividend
CN¥0.05
Ex-dividend date
May 29, 2026
P/E ratio
61.77
52-wk high
CN¥39.28
52-wk low
CN¥24.75
EPS
CN¥0.41
Shares outstanding
91.67M
No. of employees
540
Open
CN¥25.60
High
CN¥25.95
Low
CN¥24.75
Mkt. cap
2.33B
Avg. vol.
1.14M
Volume
947.70K
Dividend
0.86%
Quarterly dividend
CN¥0.05
Ex-dividend date
May 29, 2026
P/E ratio
61.77
52-wk high
CN¥39.28
52-wk low
CN¥24.75
EPS
CN¥0.41
Shares outstanding
91.67M
No. of employees
540
News stories
From sources across the web
About Suzhou Fushilai Pharmaceutical Co Ltd
CEO-
Employees540
FoundedNov 27, 2000
Headquarters-
SectorPharmaceutical industry
Websitefuslai.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
110.83M
98.67M
110.15M
92.86M
Cost of goods sold
87.88M
85.22M
92.19M
75.63M
Cost of revenue
87.88M
85.22M
92.19M
75.63M
Research and development expenses
8.79M
8.99M
9.10M
8.18M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.42M
10.14M
14.82M
11.63M
Operating expense
18.94M
18.08M
26.13M
21.83M
Total operating expenses
106.82M
103.31M
118.32M
97.45M
Operating income
4.00M
-4.63M
-8.17M
-4.59M
Other non operating income
-71.97K
-1.95M
1.74M
-4.52M
EBT including unusual items
22.09M
36.33M
-11.44M
-3.35M
EBT excluding unusual items
6.93M
13.70M
-5.38M
9.82M
Income tax expense
2.95M
6.01M
-2.34M
-579.60K
Effective tax rate
13.34%
16.55%
20.46%
17.32%
Other operating expenses
1.89M
-1.51M
3.07M
1.13M
Net income
19.14M
30.32M
-9.10M
-2.77M
Net profit margin
17.27%
30.73%
-8.26%
-2.98%
Earnings per share
-
-
-
-
Interest and investment income
3.65M
19.67M
5.74M
18.95M
Interest expense
-16.92K
-15.10K
-13.20K
-11.28K
Net interest expenses
3.63M
19.65M
5.73M
18.94M
Depreciation and amortization charges
-
-
-
-
EBITDA
15.81M
7.33M
3.56M
7.14M
Gain or loss from assets sale
68.66K
-68.66K
299.01K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer